ATX101

DRUG2 trials

Sponsors

Allay Therapeutics, Inc., Aurobac Therapeutics SAS

Conditions

Healthy ParticipantsTotal Knee Arthroplasty (Postoperative Pain)

Phase 1

Phase 1 Single Ascending Dose Study With ATX101

CompletedNCT07107802

Aurobac Therapeutics SASHealthy Participants

Start: 2025-07-19End: 2025-10-24Updated: 2025-11-28

Phase 2

Study Assessing Pain Relief After Replacement of the Knee

CompletedNCT06799845

Allay Therapeutics, Inc.Total Knee Arthroplasty (Postoperative Pain)

Start: 2025-02-03End: 2025-10-03Updated: 2025-11-04